Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Jul;66(1):62-8.
doi: 10.1038/bjc.1992.217.

Reversal of multidrug resistance by surfactants

Affiliations
Free PMC article

Reversal of multidrug resistance by surfactants

D M Woodcock et al. Br J Cancer. 1992 Jul.
Free PMC article

Abstract

Cremophor EL, a pharmacologically inactive solubilising agent, has been shown to reverse multidrug resistance (MDR). Using flow cytometric evaluation of equilibrium intracellular levels of daunorubicin (DNR), we found that eight other surface active agents will also reverse MDR. All the active detergents contain polyethoxylated moieties but have no similarities in their hydrophobic components. The properties of three polyethoxylated surfactants that showed the lowest toxicities, Cremophor, Tween 80 and Solutol HS15, were examined in more detail. The concentrations of Tween 80 and Solutol required to reverse DNR exclusion were 10-fold lower than for Cremophor. However while concentrations greater than or equal to 1:10(2) of the former two surfactants resulted in breakdown of cells, even 1:10 of Cremophor did not lyse cells. Studies of the effects of Cremophor on the uptake and efflux of DNR in normal and MDR cell types showed that Cremophor increases intracellular DNR primarily by locking the rapid efflux from the cells. This blockage of drug efflux may be mediated by a substantial alteration in the fluidity of cell membranes induced by Cremophor, as shown by decreased fluorescence anisotropy of a membrane probe. Consistent with these data, coinjection of adriamycin plus Cremophor into mice carrying a multidrug resistant P388 transplantable tumour significantly increased the survival time of the mice compared with adriamycin treatment alone.

PubMed Disclaimer

References

    1. J Urol. 1988 Apr;139(4):862-5 - PubMed
    1. J Natl Cancer Inst. 1988 Mar 2;80(1):14-20 - PubMed
    1. J Natl Cancer Inst. 1987 Oct;79(4):831-6 - PubMed
    1. J Clin Oncol. 1987 Dec;5(12):1922-7 - PubMed
    1. Cancer Res. 1990 Jul 15;50(14):4199-203 - PubMed

Publication types

MeSH terms